FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileZimmer Biomet Holdings, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ZBH
Zimmer Biomet Holdings, Inc. Stock AnalysisComprehensive stock analysis for Zimmer Biomet Holdings, Inc. (ZBH) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisZBH
ZBH
Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ZBH
  1. Home
  2. Stocks
  3. Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

🇺🇸ZBH•NYSE

Zimmer Biomet Holdings, Inc.

🇺🇸ZBH•NYSE
Market cap
$19.19B
Sentiment

Your view on ZBH

Mkt Cap
$19.19B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Zimmer Biomet Holdings, Inc.

Industry
Medical - Devices
Sector
Healthcare
CEO
Ivan Tornos
Headquarters
345 East Main Street, Warsaw, IN, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Ivan Tornos
Headquarters
345 East Main Street, Warsaw, IN, US
Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T.

products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues.

It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015.

Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Zimmer Biomet Holdings, Inc. from FRC's valuation model, read against the market price. ZBH last traded at $101.41, 25.6× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Zimmer Biomet Holdings, Inc.. Starting points for Zimmer Biomet Holdings, Inc.: P/E 25.6, EPS $4.03, beta 0.47 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Zimmer Biomet Holdings, Inc.. Zimmer Biomet Holdings, Inc. paid $0.96 per share over the last year — a 0.9% yield at the current $101.41 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Zimmer Biomet Holdings, Inc.. Trailing twelve-month EPS for Zimmer Biomet Holdings, Inc. stands at $4.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$109.77

average of 13 firms, last 12 months

 

$109.77

Low $93.00

Median $110.00

High $140.00

 

Analyst Ratings

Hold17 firms, last 12 months
  • Strong Buy0
  • Buy6
  • Hold11
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$2.49$2.08$8.55$8.98
Low estimate$2.46$2.03$8.53$8.76
High estimate$2.52$2.15$8.56$9.13
No. of analysts16111616
Year-ago EPS$2.42$2.09$3.551—
Growth+3.1%-0.7%——

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$2.29B$2.15B$8.61B$8.90B
Low estimate$2.28B$2.12B$8.60B$8.82B
High estimate$2.30B$2.18B$8.63B$8.98B
No. of analysts1591919
Year-ago revenue$2.24B$2.09B$8.23B—
Growth+2.0%+2.9%+4.7%—
Recent analyst actions15 rating and price-target changes, latest Nov 17, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Zimmer Biomet Holdings, Inc.. Zimmer Biomet Holdings, Inc. has reported as a listed company since 2001. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ZBH20 companies · 8 funds
Compare ZBH with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • ALGNAlign Technology, Inc.Medical - Devices$11.7B
  • BSXBoston Scientific CorporationMedical - Devices$63.3B
  • EWEdwards Lifesciences CorporationMedical - Devices$61.6B
  • GEHCGE HealthCare Technologies Inc.Medical - Devices$37.5B
  • MDTMedtronic plcMedical - Devices$131.6B
  • OFIXOrthofix Medical Inc.Medical - Devices$277M
  • PHGKoninklijke Philips N.V.Medical - Devices$29.3B
  • SNNSmith & Nephew plcMedical - Devices$13.0B

More Medical - Devices companies

  • ARX.AXAroa Biosurgery LimitedASX
  • ASAPFAurora Spine CorporationOTC$16M
  • ASG.VAurora Spine CorporationTSXV$16M
  • ASTI.CNAquarius Surgical Technologies Inc.CNQ
  • AT1.AXAtomo Diagnostics LimitedASX
  • ATECAlphatec Holdings, Inc.NASDAQ$1.1B
  • AVH.AXAVITA Medical, Inc.ASX
  • AVHHLAVITA Medical, Inc.OTC$99M
  • AVRAnteris Technologies Global Corp.NASDAQ$556M
  • AVR.AXAnteris Technologies LtdASX
  • AXGNAxoGen, Inc.NASDAQ$3.3B
  • BBNXBeta Bionics, Inc.NASDAQ$684M

ETFs holding Zimmer Biomet Holdings, Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.03%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.02%
  • VBVanguard Small-Cap ETF$76.9B in assets0.22%
  • MOATVanEck Morningstar Wide Moat ETF$11.9B in assets2.66%
  • OAKMOakmark U.S. Large Cap ETF$1.2B in assets2.65%
  • FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets2.65%
  • IHIiShares US Medical Devices ETF$4.0B in assets2.46%
  • FTAFirst Trust Large Cap Value AlphaDEX Fund$1.5B in assets0.77%

Largest holders first, then the funds most concentrated in ZBH.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Zimmer Biomet Holdings, Inc., and how their positions are changing. At a $19.19B market value, institutional positions materially move Zimmer Biomet Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Zimmer Biomet Holdings, Inc. executives and directors. Shares of Zimmer Biomet Holdings, Inc. have traded between $85.33 and $114.44 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Zimmer Biomet Holdings, Inc.. Zimmer Biomet Holdings, Inc. is a $19.19B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Zimmer Biomet Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Zimmer Biomet Holdings, Inc.. Coverage tracks Zimmer Biomet Holdings, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Zimmer Biomet Holdings, Inc.

ZBH Analysis
Fair
Past2
Growth4
Health3
Profit2
Value1

News

Latest Market News